Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
Gorcenco, Sorina LU
; Vaz, Frédéric M.
; Tracewska-Siemiatkowska, Anna
; Tranebjærg, Lisbeth
; Cremers, Frans P.M.
; Ygland, Emil
LU
; Kicsi, Jenő
; Rendtorff, Nanna Dahl
; Möller, Claes
and Kjellström, Ulrika
LU
, et al.
(2019)
In Parkinsonism & Related Disorders
61.
p.245-247
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/52ba4849-9c48-42f9-98e4-d655b2fdd48c
- author
- Gorcenco, Sorina
LU
; Vaz, Frédéric M.
; Tracewska-Siemiatkowska, Anna
; Tranebjærg, Lisbeth
; Cremers, Frans P.M.
; Ygland, Emil
LU
; Kicsi, Jenő
; Rendtorff, Nanna Dahl
; Möller, Claes
and Kjellström, Ulrika
LU
, et al. (More)
- Gorcenco, Sorina
LU
; Vaz, Frédéric M.
; Tracewska-Siemiatkowska, Anna
; Tranebjærg, Lisbeth
; Cremers, Frans P.M.
; Ygland, Emil
LU
; Kicsi, Jenő
; Rendtorff, Nanna Dahl
; Möller, Claes
; Kjellström, Ulrika
LU
; Andréasson, Sten
LU
and Puschmann, Andreas
LU
(Less)
- organization
- publishing date
- 2019
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Adult, Ataxia, Brown-Vialetto-Van Laere syndrome-2, BVVLS2, Pharmacokinetics, Recessive, Riboflavin transporter deficiency, SLC52A2, Treatment
- in
- Parkinsonism & Related Disorders
- volume
- 61
- pages
- 3 pages
- publisher
- Elsevier
- external identifiers
-
- scopus:85065409488
- pmid:30343981
- ISSN
- 1873-5126
- DOI
- 10.1016/j.parkreldis.2018.10.017
- language
- English
- LU publication?
- yes
- id
- 52ba4849-9c48-42f9-98e4-d655b2fdd48c
- date added to LUP
- 2019-05-23 14:40:07
- date last changed
- 2025-10-16 21:41:29
@article{52ba4849-9c48-42f9-98e4-d655b2fdd48c,
author = {{Gorcenco, Sorina and Vaz, Frédéric M. and Tracewska-Siemiatkowska, Anna and Tranebjærg, Lisbeth and Cremers, Frans P.M. and Ygland, Emil and Kicsi, Jenő and Rendtorff, Nanna Dahl and Möller, Claes and Kjellström, Ulrika and Andréasson, Sten and Puschmann, Andreas}},
issn = {{1873-5126}},
keywords = {{Adult; Ataxia; Brown-Vialetto-Van Laere syndrome-2; BVVLS2; Pharmacokinetics; Recessive; Riboflavin transporter deficiency; SLC52A2; Treatment}},
language = {{eng}},
pages = {{245--247}},
publisher = {{Elsevier}},
series = {{Parkinsonism & Related Disorders}},
title = {{Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?}},
url = {{http://dx.doi.org/10.1016/j.parkreldis.2018.10.017}},
doi = {{10.1016/j.parkreldis.2018.10.017}},
volume = {{61}},
year = {{2019}},
}